Foghorn Therapeutics (FHTX) FCF Margin (QoQ) (2020 - 2026)
Foghorn Therapeutics (FHTX) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Foghorn Therapeutics |
282.33 Mn |
193.42 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-53,305.00 |
| Dec 31, 2025 |
-1,067.00 |
| Sep 30, 2025 |
4,747.00 |
| Jun 30, 2025 |
12,498.00 |
| Mar 31, 2025 |
47,695.00 |
| Dec 31, 2024 |
-60,883.00 |
| Sep 30, 2024 |
9,962.00 |
| Jun 30, 2024 |
21,218.00 |
| Mar 31, 2024 |
-12,566.00 |
| Dec 31, 2023 |
-29,545.00 |
| Sep 30, 2023 |
40,891.00 |
| Jun 30, 2023 |
2,203.00 |
| Mar 31, 2023 |
10,481.00 |
| Dec 31, 2022 |
-38,544.00 |
| Sep 30, 2022 |
33,304.00 |
| Jun 30, 2022 |
-756,591.00 |
| Mar 31, 2022 |
526,533.00 |
| Dec 31, 2021 |
5.22 Mn |
| Sep 30, 2021 |
-4.35 Mn |
| Jun 30, 2021 |
166,256.00 |
